Unknown

Dataset Information

0

Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB.

ABSTRACT:

SUBMITTER: Imai M 

PROVIDER: S-EPMC9749618 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Humoral immune evasion of the omicron subvariants BQ.1.1 and XBB.
| S-EPMC9729000 | biostudies-literature
Unknown Characterization of Omicron BA.4.6, XBB, and BQ.1.1 subvariants in hamsters.
| S-EPMC10943235 | biostudies-literature
Unknown Antigenic characterization of SARS-CoV-2 Omicron subvariants XBB.1.5, BQ.1, BQ.1.1, BF.7 and BA.2.75.2.
| S-EPMC10015517 | biostudies-literature
Unknown Assessment of neutralization susceptibility of Omicron subvariants XBB.1.5 and BQ.1.1 against broad-spectrum neutralizing antibodies through epitopes mapping.
| S-EPMC10565033 | biostudies-literature
Unknown Sotrovimab therapy elicits antiviral activities against Omicron BQ.1.1 and XBB.1.5 in sera of immunocompromised patients.
| S-EPMC11232389 | biostudies-literature
Unknown Activity of Sotrovimab against BQ.1.1 and XBB.1 Omicron sublineages in a hamster model.
| S-EPMC10191698 | biostudies-literature
Unknown Antiviral activities of sotrovimab against BQ.1.1 and XBB.1.5 in sera of treated patients.
| S-EPMC10312842 | biostudies-literature
Unknown In Vitro Efficacy of Antivirals and Monoclonal Antibodies against SARS-CoV-2 Omicron Lineages XBB.1.9.1, XBB.1.9.3, XBB.1.5, XBB.1.16, XBB.2.4, BQ.1.1.45, CH.1.1, and CL.1.
| S-EPMC10611309 | biostudies-literature
Unknown Striking antibody evasion of SARS-CoV-2 Omicron sub-lineages BQ.1.1, XBB.1 and CH.1.1.
| S-EPMC10309178 | biostudies-literature
Unknown Poor neutralizing antibody responses against SARS-CoV-2 Omicron BQ.1.1 and XBB in Norway in October 2022.
| S-EPMC10236499 | biostudies-literature